About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Prostate Cancer and Prostatic Diseases
›
top-articles
Prostate Cancer and Prostatic Diseases
4.3
(top 10%)
impact factor
1.8K
(top 10%)
papers
40.8K
(top 10%)
citations
80
(top 10%)
h
-index
4.5
(top 10%)
impact factor
2.3K
all documents
43.5K
doc citations
110
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer
Prostate Cancer and Prostatic Diseases
2006
373
2
Components of the metabolic syndrome—risk factors for the development of benign prostatic hyperplasia
Prostate Cancer and Prostatic Diseases
1998
260
3
Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting
Prostate Cancer and Prostatic Diseases
2010
255
4
Proteinchip® surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures
Prostate Cancer and Prostatic Diseases
1999
239
5
ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification
Prostate Cancer and Prostatic Diseases
2010
227
6
Pathologic progression of autochthonous prostate cancer in the TRAMP model
Prostate Cancer and Prostatic Diseases
1999
222
7
Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations
Prostate Cancer and Prostatic Diseases
2019
215
8
Increasing incidence of metastatic prostate cancer in the United States (2004–2013)
Prostate Cancer and Prostatic Diseases
2016
205
9
Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population-based analysis of US Medicare beneficiaries, 1999–2006
Prostate Cancer and Prostatic Diseases
2011
183
10
Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes
Prostate Cancer and Prostatic Diseases
2009
180
11
Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases
Prostate Cancer and Prostatic Diseases
2013
179
12
Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation
Prostate Cancer and Prostatic Diseases
2009
174
13
A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer
Prostate Cancer and Prostatic Diseases
2013
170
14
Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve
Prostate Cancer and Prostatic Diseases
2004
158
15
Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies
Prostate Cancer and Prostatic Diseases
2013
155
16
Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines
Prostate Cancer and Prostatic Diseases
2006
150
17
Paucity of PD-L1 expression in prostate cancer: innate and adaptive immune resistance
Prostate Cancer and Prostatic Diseases
2015
149
18
The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo
Prostate Cancer and Prostatic Diseases
2006
148
19
Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting
Prostate Cancer and Prostatic Diseases
2016
142
20
Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence
Prostate Cancer and Prostatic Diseases
2010
139
21
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature
Prostate Cancer and Prostatic Diseases
2012
139
22
A molecular signature of PCA3 and ERG exosomal RNA from non-DRE urine is predictive of initial prostate biopsy result
Prostate Cancer and Prostatic Diseases
2015
138
23
Impact of diet on prostate cancer: a review
Prostate Cancer and Prostatic Diseases
2005
137
24
Wnt signalling and prostate cancer
Prostate Cancer and Prostatic Diseases
2005
135
25
Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer
Prostate Cancer and Prostatic Diseases
2018
134
26
Microvessel density in prostate carcinoma
Prostate Cancer and Prostatic Diseases
2002
133
27
A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo
Prostate Cancer and Prostatic Diseases
2005
133
28
Metabolic syndrome and lower urinary tract symptoms: the role of inflammation
Prostate Cancer and Prostatic Diseases
2013
132
29
Meta-analysis of metabolic syndrome and prostate cancer
Prostate Cancer and Prostatic Diseases
2017
130
30
miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression
Prostate Cancer and Prostatic Diseases
2010
128
31
A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy
Prostate Cancer and Prostatic Diseases
2014
128
32
The microbiome in prostate inflammation and prostate cancer
Prostate Cancer and Prostatic Diseases
2018
125
33
Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database
Prostate Cancer and Prostatic Diseases
2009
124
34
Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy
Prostate Cancer and Prostatic Diseases
2016
122
35
PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges
Prostate Cancer and Prostatic Diseases
2016
121
36
The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer
Prostate Cancer and Prostatic Diseases
2005
120
37
Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis
Prostate Cancer and Prostatic Diseases
2017
120
38
Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy
Prostate Cancer and Prostatic Diseases
2011
117
39
Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer
Prostate Cancer and Prostatic Diseases
2014
116
40
A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer—the UK NCRN Pomi-T study
Prostate Cancer and Prostatic Diseases
2014
116
41
Soy isoflavone genistein in prevention and treatment of prostate cancer
Prostate Cancer and Prostatic Diseases
2008
115
42
Increased dietary and circulating lycopene are associated with reduced prostate cancer risk: a systematic review and meta-analysis
Prostate Cancer and Prostatic Diseases
2017
114
43
The emerging role of the PI3-K-Akt pathway in prostate cancer progression
Prostate Cancer and Prostatic Diseases
2005
113
44
Therapeutic potential of curcumin in human prostate cancer—I. curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells
Prostate Cancer and Prostatic Diseases
2000
109
45
Novel role for the transient receptor potential channel TRPM2 in prostate cancer cell proliferation
Prostate Cancer and Prostatic Diseases
2010
107
46
The effect of testosterone replacement therapy on prostate cancer: a systematic review and meta-analysis
Prostate Cancer and Prostatic Diseases
2014
106
47
Maximum androgen-blockade with medical or surgical castration in advanced prostate cancer: A meta-analysis of nine published randomized controlled trials and 4128 patients using flutamide
Prostate Cancer and Prostatic Diseases
1999
104
48
Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer
Prostate Cancer and Prostatic Diseases
2011
103
49
Oxidative stress in prostate cancer: changing research concepts towards a novel paradigm for prevention and therapeutics
Prostate Cancer and Prostatic Diseases
2013
103
50
Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project
Prostate Cancer and Prostatic Diseases
2017
103
site/software ©
exaly
; All materials licenced under
CC by-SA
.